Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease.
Journal: Neurobiology of disease
Published: July 17, 2019
Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples.
Journal: Acta neuropathologica
Published: May 24, 2019
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
Journal: Nature
Published: August 02, 2017
Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
Journal: Neuropathology and applied neurobiology
Published: October 19, 2016
Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity.
Journal: Cell reports
Published: December 16, 2015
Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
Journal: Journal of cell science
Published: March 29, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026